Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathy of Undetermined Significance”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Not applicableLooking for participantsNCT05539079
What this trial is testing

A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
MGUS
Oxford University Hospitals NHS Trust 2,000
Not applicableEnrolling By InvitationNCT06472830
What this trial is testing

MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 1,000
Not applicableStudy completedNCT02033928
What this trial is testing

Comprehensive Frailty Assessment

Who this might be right for
Myeloma, MultipleParaproteinemiasHematologic Neoplasms
Ohio State University Comprehensive Cancer Center 111
Not applicableStudy completedNCT03521596
What this trial is testing

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

Who this might be right for
Waldenstrom Macroglobulinemia
Fondazione Italiana Linfomi - ETS 300
Early research (Phase 1)Study completedNCT03820817
What this trial is testing

Rifaximin in Patients With Monoclonal Gammopathy

Who this might be right for
IgA Monoclonal GammopathyIgG Monoclonal GammopathyIgM Monoclonal Gammopathy+6 more
Emory University 50
Testing effectiveness (Phase 2)Study completedNCT03046381
What this trial is testing

Tocilizumab in Patients With Schnitzler's Syndrome

Who this might be right for
Schnitzler's Syndrome
Karoline Krause 8
Not applicableNot Yet RecruitingNCT06987708
What this trial is testing

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Who this might be right for
Monoclonal Gammopathy of Uncertain SignificanceSmoldering Myeloma
Hackensack Meridian Health 67
Large-scale testing (Phase 3)Study completedNCT00259974
What this trial is testing

RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy

Who this might be right for
Polyneuropathy
Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT05965115
What this trial is testing

The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Shanghai Zhongshan Hospital 10,000
Testing effectiveness (Phase 2)Study completedNCT01390350
What this trial is testing

Ilaris® Effects in Schnitzler Syndrome (ILESCH)

Who this might be right for
Schnitzler Syndrome
Charite University, Berlin, Germany 20
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT04439006
What this trial is testing

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10
Testing effectiveness (Phase 2)Study completedNCT03095118
What this trial is testing

Daratumumab in Treatment of PGNMID and C3 GN

Who this might be right for
Membranoproliferative Glomerulonephritis
Fernando Fervenza 12
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Testing effectiveness (Phase 2)WithdrawnNCT04213274
What this trial is testing

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Who this might be right for
Schnitzler SyndromeUrticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)
R-Pharm Overseas, Inc.
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Not applicableUnknownNCT06489613
What this trial is testing

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

Who this might be right for
M ProteinMonoclonal GammopathyMonoclonal Gammopathy of Undetermined Significance
Jian Li 15,600
Testing effectiveness (Phase 2)Looking for participantsNCT06083922
What this trial is testing

CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center 20
Next Page